Last update:
Oncology news
New anemia in adults may be an early warning sign of cancer
Anemia detected in health care is associated with an increased risk of both cancer and higher mortality, according to a new population-based study from Karolinska Institutet, published in BMJ Oncology. The findings may help ...
3 hours ago
0
0
Shifts in cancer mortality: Place of living increasingly determines where historic drop in cancer mortality reaches
In 1991, the U.S. experienced a significant shift in cancer death rates, as, for the first time, deaths began a steady decline that continues to the present day. Researchers at Mississippi State's Social Science Research ...
23 hours ago
0
32
Researchers map prostate immune niches, showing T cells persist months in mice
More than 35,000 men in the United States die from prostate cancer each year. Now, a new study reveals the immune cell weaponry we might use to save lives.
Apr 11, 2026
0
6
Antidepressant unable to prevent chemotherapy-associated nerve damage
A randomized trial conducted by the Alliance for Clinical Trials in Oncology has found that duloxetine, a medication commonly used to treat chronic pain and psychiatric conditions, does not prevent nerve damage caused by ...
Apr 11, 2026
0
5
Study finds no increased risk of respiratory cancers from asbestos-free talc exposure
In a systematic review and meta-analysis, researchers found that occupational exposure to talc that is not contaminated with asbestos is not associated with an increase in the risk of lung cancer, mesothelioma, or laryngeal ...
Apr 11, 2026
0
2
Not wanting to eat protein may be early herald of cancer cachexia
A majority of people with advanced cancers endure cachexia, a muscle-, fat-, and organ-wasting condition that is currently incurable and can be life-threatening. Detecting and intervening early can slow progression, but poor ...
Apr 10, 2026
0
17
COVID-19's lingering shadow: The molecular link between SARS-CoV-2 and lung cancer risk
A new study suggests that COVID-19 may slightly increase the risk of lung cancer by triggering a biological chain reaction in the lungs, driven by the virus's spike protein, that promotes inflammation, scarring, and tumor-friendly ...
Apr 10, 2026
0
9
Could gene edits solve obstacles to treatment for the most common types of cancer?
Since 2017, a personalized immunotherapy called Chimeric Antigen Receptor, or CAR-T cell treatment, has worked wonders to treat patients with blood cancers such as leukemia. But when it comes to treating solid tumor cancers, ...
Apr 10, 2026
0
7
A lung cancer that changes its identity may be hiding in plain sight
A new study co-led by the Institute for Systems Biology (ISB) shows that some lung cancers can change identity as they evolve, shifting from one cancer type to another in ways that may make them more aggressive and harder ...
Apr 10, 2026
0
10
Leukemia cells use a sugar-coated protein to hide from the immune system, study reveals
Leukemia is adept at dodging the immune system, making it resistant to many of the newest generation of cancer immunotherapies. Now, researchers have identified a key part of the cancer's disguise: a protein called CD43 on ...
Apr 10, 2026
0
5
Reprogramming regulatory T cells could help immunotherapy work in pancreatic cancer
Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer—and identified a promising strategy to overcome that resistance. The study, published ...
Apr 10, 2026
0
17
How an overactive immune system can drive cancer
The immune system is designed to protect us against viruses and bacteria. In autoimmune diseases, however, the immune system instead attacks the body's own cells. Conditions such as systemic lupus erythematosus (lupus) and ...
Apr 9, 2026
0
10
Long non-coding RNA may be a promising therapeutic target for cancer
Northwestern Medicine scientists have discovered that a specific long non-coding RNA activates oncogenic signaling pathways in prostate cancer cells and drives tumor progression, underscoring its potential as a therapeutic ...
Apr 9, 2026
0
5
Why anti-cancer drugs do not always live up to expectations
For more than a decade, a class of drugs called BET inhibitors has been tested in cancer trials with high expectations. The biology looked promising. Many cancers depend on oncogenes that "Bromo- and Extra-Terminal domain" ...
Apr 9, 2026
0
12
AI outperforms doctors at summarizing complex cancer pathology reports
AI models can generate more complete summaries of complex cancer pathology reports than physicians, according to a new Northwestern Medicine study that tested six models developed by Meta, Google, DeepSeek and Mistral AI.
Apr 9, 2026
0
8
Brain tumors: 3D experimental system to evaluate candidate drugs against glioma
Glioma is a tumor of the central nervous system that originates from glial cells, which support neurons in the brain. In the less aggressive, slow-progressing forms, gliomas are often found in children and youth. Glial tumors ...
Apr 9, 2026
0
3
New method provides clearer view of how genome functions in cancer
Researchers at the University of Minnesota Medical School have developed a new method called PARTAGE that provides a clearer picture of how the genome is regulated and disrupted in diseases like cancer. The findings were ...
Apr 9, 2026
0
2
New tool offers personalized approach to blood cancer care
Researchers have developed a new tool to help clinicians tailor personalized treatment plans for patients with a rare blood cancer called chronic myelomonocytic leukemia (CMML). The tool, called the international CMML Prognostic ...
Apr 9, 2026
0
4
Cancer risk is significantly higher for adults who have never married, finds large study
Adults who have never been married face a significantly higher risk of developing cancer than those who have been married, according to a large U.S. study of more than four million cases. The increased risk spans nearly every ...
Apr 8, 2026
0
238
Extra chromosomes may seed childhood leukemia years before disease, study suggests
B-cell acute lymphoblastic leukemia is the most common form of childhood cancer. In this type of cancer, which affects blood cells, one of the most common abnormalities is the presence of cells with an excess of chromosomes ...
Apr 8, 2026
0
6
A urine test that could change the course of bladder cancer care
Bladder cancer arises from the lining of the bladder, the organ that stores urine, and is one of the most common cancers in the United States. Most patients are diagnosed at an early stage called non-muscle invasive bladder ...
Apr 8, 2026
0
6
Sequencing method exposes hidden gaps in immune signaling by tracking RNA and protein together
A new single-cell technology is giving scientists their clearest view yet of immune cell behavior—capturing not just genetic intent, but real-time activity. By measuring RNA and proteins simultaneously, it reveals cytokine ...
Apr 8, 2026
0
7
Antibody drugs with strong immune cell binding linked to allergic reactions
Antibody therapeutics are laboratory-made proteins designed to work like the body's natural antibodies. They are widely used to treat diseases such as cancer by binding to specific targets, including cancer cells or inflammatory ...
Apr 8, 2026
0
8
Blocking RNA 'cleanup' may expose hidden cancer antigens, boosting immunotherapy
A new method of making cancer cells more visible to the immune system could improve how well immunotherapy works against a range of different tumors, potentially leading to more effective treatment for patients, according ...
Apr 8, 2026
0
3
Researchers find new target to sensitize pancreatic tumors to immunotherapy
Researchers at The University of Texas MD Anderson Cancer Center have identified an epigenetic target for replication stress, called DPY30, that could sensitize pancreatic tumors to immunotherapy and serve as a predictive ...
Apr 8, 2026
0
4
